PenderFund Capital Management’s 89bio ETNB Stock Holding History

PenderFund Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,400	Closed	-$138K	–	233
2025 Q3	$138K	Buy	+9,400	New	+$95.8K	0.02%	128

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PenderFund Capital Management's ETNB Position: Q4 2025 in Review

PenderFund Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 9,400 shares — an estimated $138K sold.

PenderFund Capital Management first reported a position in ETNB in Q3 2025 and held it in 1 quarter. The position peaked at $138K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

PenderFund Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
PenderFund Capital Management sold 9,400 89bio shares in Q4 2025, an estimated $138K.
PenderFund Capital Management first reported a position in 89bio in Q3 2025 and held it in 1 quarter.
PenderFund Capital Management's 89bio position peaked at $138K in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on PenderFund Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.